Literature DB >> 20173392

TNF and bone.

Jean-Pierre David1, Georg Schett.   

Abstract

Bone is subject to permanent remodeling during development and through life. This activity is essential for (a) proper shaping and growth of each bone during development; (b) maintenance of bone mass as well as structural integrity of the micro architecture of bone through adult life, and (c) tissue repair needed for healing of fracture as well as of micro-damage. In addition to genetically linked rare developmental diseases, disturbances in bone remodeling are causing common bone pathologies, which severely impair the quality of life of patients. Among them are postmenopausal osteoporosis and local as well as systemic bone loss observed in chronic inflammatory diseases such as rheumatoid arthritis. The role of TNF-alpha in mediating bone remodeling will be presented and discussed in this chapter. Copyright (c) 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20173392     DOI: 10.1159/000289202

Source DB:  PubMed          Journal:  Curr Dir Autoimmun        ISSN: 1422-2132


  20 in total

Review 1.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

2.  [Local and systemic bone effects of rheumatoid arthritis].

Authors:  M Rauner; L C Hofbauer; M Aringer
Journal:  Z Rheumatol       Date:  2012-12       Impact factor: 1.372

3.  Insights into bone health in Duchenne muscular dystrophy.

Authors:  Victor H Morgenroth; Lauren P Hache; Paula R Clemens
Journal:  Bonekey Rep       Date:  2012-02-01

4.  TNF activates calcium-nuclear factor of activated T cells (NFAT)c1 signaling pathways in human macrophages.

Authors:  Anna Yarilina; Kai Xu; Janice Chen; Lionel B Ivashkiv
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 5.  Synovial tissue heterogeneity and peripheral blood biomarkers.

Authors:  Serena Bugatti; Antonio Manzo; Michele Bombardieri; Barbara Vitolo; Frances Humby; Stephen Kelly; Carlomaurizio Montecucco; Costantino Pitzalis
Journal:  Curr Rheumatol Rep       Date:  2011-10       Impact factor: 4.592

6.  [Multimorbidity in elderly rheumatic patients part 1].

Authors:  H-J Lakomek; T Brabant; M Lakomek; D Lüttje
Journal:  Z Rheumatol       Date:  2013-08       Impact factor: 1.372

7.  Bone fragility beyond strength and mineral density: Raman spectroscopy predicts femoral fracture toughness in a murine model of rheumatoid arthritis.

Authors:  Jason A Inzana; Jason R Maher; Masahiko Takahata; Edward M Schwarz; Andrew J Berger; Hani A Awad
Journal:  J Biomech       Date:  2012-12-20       Impact factor: 2.712

8.  Divergent resorbability and effects on osteoclast formation of commonly used bone substitutes in a human in vitro-assay.

Authors:  Johannes Keller; Silja Brink; Björn Busse; Arndt F Schilling; Thorsten Schinke; Michael Amling; Tobias Lange
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

Review 9.  Research progress in the mechanism of effect of PRP in bone deficiency healing.

Authors:  Ning Zhang; Yong-Ping Wu; Sheng-Jun Qian; Chong Teng; Shuai Chen; Hang Li
Journal:  ScientificWorldJournal       Date:  2013-04-04

10.  Performance of Nano-Hydroxyapatite/Beta-Tricalcium Phosphate and Xenogenic Hydroxyapatite on Bone Regeneration in Rat Calvarial Defects: Histomorphometric, Immunohistochemical and Ultrastructural Analysis.

Authors:  Igor da Silva Brum; Lucio Frigo; Paulo Goncalo Pinto Dos Santos; Carlos Nelson Elias; Guilherme Aparecido Monteiro Duque da Fonseca; Jorge Jose de Carvalho
Journal:  Int J Nanomedicine       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.